(Q33472890)

English

Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies

scientific article published in July 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies (English)

1 reference

Europe PubMed Central

27 July 2017

gram-positive bacteria

0 references

antimicrobial resistance

1 reference

based on heuristic

inferred from title

Drosos E. Karageorgopoulos

object named as

Drosos E Karageorgopoulos

5

0 references

Matthew E. Falagas

1

object named as

Matthew E Falagas

1 reference

Europe PubMed Central

27 July 2017

Petros I Rafailidis

4

object named as

Petros I Rafailidis

1 reference

Europe PubMed Central

27 July 2017

Ioannis Gkegkes

3

object named as

Ioannis D Gkegkes

1 reference

Europe PubMed Central

27 July 2017

author name string

Nikos Roussos

2

1 reference

Europe PubMed Central

27 July 2017

language of work or name

0 references

publication date

1 July 2009

1 reference

Europe PubMed Central

27 July 2017

Expert Opinion on Investigational Drugs

1 reference

Europe PubMed Central

27 July 2017

18

1 reference

Europe PubMed Central

27 July 2017

921-944

1 reference

Europe PubMed Central

27 July 2017

7

1 reference

Europe PubMed Central

27 July 2017

Antimicrobial resistance in gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Vancomycin-resistant enterococci: colonization, infection, detection, and treatment

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Current challenges in treating MRSA: what are the options?

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Antibiotic-resistant bugs in the 21st century--a clinical super-challenge

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Fosfomycin, antimicrobial activity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Fosfomycin trometamol

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Fosfomycin: use beyond urinary tract and gastrointestinal infections

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

In vitro and in vivo study of fosfomycin in methicillin-resistant Staphylococcus aureus septicaemia

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

The microbiological efficacy of the combination of fosfomycin and vancomycin against clinically relevant staphylococci

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

In vitro activities of new antimicrobial agents against multiresistant Staphylococcus aureus isolated from septicemic patients during a Belgian national survey from 1983 to 1985.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Antibiotic resistance of Staphylococcus aureus in urban experience: 6 month study in Aquitaine

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

In vitro activity of 21 antimicrobials against vancomycin-resistant Staphylococcus aureus (VRSA) and heteroVRSA (hVRSA).

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Emergence of methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin genes in central Europe

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

[Antibiotics resistance of meticilline-resistant Staphylococcus aureus: detection of the first glycopeptides low sensibility strains in Tunisia]

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Characterisation of non-multiresistant methicillin-resistant Staphylococcus aureus (including EMRSA-15) in Kuwait Hospitals.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Risk factors associated with methicillin-resistant Staphylococcus aureus infection in patients admitted to the ED.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Evolution of antibiotic resistance of Streptococcus pneumoniae: results of Alsace observatory in 2005

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

In-vitro activity of fosfomycin against vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Enterococcal glycopeptide resistance at an Italian teaching hospital.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium: potential utility of fosfomycin

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Emergence of the vanA genotype among Enterococcus gallinarum isolates colonising the intestinal tract of patients in a university hospital in Rio de Janeiro, Brazil.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Bactericidal activity of cefotaxime and fosfomycin in cerebrospinal fluid during the treatment of rabbit meningitis experimentally induced by methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Comparison of fosfomycin and vancomycin therapy for experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Single- and combination-antibiotic therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Synergism between cefotaxime and fosfomycin in the therapy of methicillin and gentamicin resistant Staphylococcus aureus infection in rabbits.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Synergistic effect of fosfomycin and arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Identification of a variant "Rome clone" of methicillin-resistant Staphylococcus aureus with decreased susceptibility to vancomycin, responsible for an outbreak in an intensive care unit.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Panton-Valentine leukocidin-producing Staphylococcus aureus infections: report of 4 French cases

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Gene cassettes potentially encoding fosfomycin resistance determinants

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Plasmid-encoded fosfomycin resistance

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Antimicrobial activity of fosfomycin in vitro.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Enhancement of the susceptibility of Staphylococcus aureus to phagocytosis after treatment with fosfomycin compared with other antimicrobial agents.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Intracellular bactericidal activity of fosfomycin against staphylococci: A comparison with other antibiotics

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Fosfomycin in the treatment of bacterial infections: summary of clinical trials in Japan

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Fosfomycin in paediatric cancer patients: a feasible alternative to glycopeptides?

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Single dose fosfomycin trometamol versus multiple dose nitrofurantoin in pregnant women with bacteriuria: preliminary results

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

The effect of fosfomycin on neutrophil function

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Role of fosfomycin tromethamine in modulating non-specific defence mechanisms in chronic uremic patients towards ESBL-producing Escherichia coli.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Fosfomycin inhibits neutrophil function via a protein kinase C-dependent signaling pathway

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Bacteriological evaluation of fosfomycin in clinical studies

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Introducing fosfomycin for surgical prophylaxis--emergence of resistance in aerobic faecal gram-negative bacteria of in-patients, but not among strains causing infection after elective colorectal procedures

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Activity of the trometamol salt of fosfomycin in an in vitro model of the treatment of bacterial cystitis

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Penicillin-binding proteins and bacterial resistance to beta-lactams

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

In vitro activity of fosfomycin in combination with various antistaphylococcal substances.

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Factors Predicting Mortality in Necrotizing Community-Acquired Pneumonia Caused by Staphylococcus aureus Containing Panton-Valentine Leukocidin

1 reference

https://api.crossref.org/works/10.1517%2F13543780902967624

21 January 2018

Identifiers

10.1517/13543780902967624

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33472890&oldid=2017472691"